Please join the CDC's Division of Blood Disorders and featured presenter Dr. Alexis Thompson for a webinar on BMT and other curative approaches to thalassemia on June 24, 2021, from 2:00-3:00 pm ET.
Join The RUNX1 Research Program (RRP), the Platelet Disorder Support Association (PDSA), and FWGBD for a Webinar on inherited platelet disorders on June 28 from 11 am -12 pm EST.
The World Federation on Hemophilia will be hosting its Global Summit on Women & Girls with Bleeding Disorders from July 8-10, 2021.
Please plan to join ISTH on June 1st, 2021, from 09:30 - 10:30 EST, for a webinar on how COVID-19 has brought challenges for hemostasis and thrombosis care.
The Foundation for Women & Girls with Blood Disorders is proud to announce the recent appointment of its newest board members, Sarah O’Brien, MD, MSc and Jeffrey H. Lawson, MD, PhD.
The Anticoagulation Forum has issued new interim clinical guidance on thromboembolism and anticoagulant therapy during the COVID-19.
ISTH has issued interim guidance for the diagnosis and treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) and is designed to inform the management of suspected thrombosis in subjects who have recently received the AstraZeneca or Johnson & Johnson vaccines.
Please join NHF for its April Webinar Series on Wednesdays from 2-3 pm ET on a range of topics of interest to the blood disorder community.
Join the American Heart Association, American Society of Health System Pharmacists, and the Anticoagulation Forum on Thursday, March 18, at 1 pm ET for a webinar on Structural Racism as a Fundamental Driver of Health Disparities.
Dr. Jim Bussel commented on the rare incidence of patients who received the COVID-19 vaccine and developed ITP in a recent New York Times article to help providers identify the best therapies for treatment and improve patient care.